Marco Sposito: Bringing New Research Questions Back to Verona After ESMO 2026
Marco Sposito/LinkedIn

Marco Sposito: Bringing New Research Questions Back to Verona After ESMO 2026

Marco Sposito, PHD Student at Università degli Studi di Verona, shared on LinkedIn:

“Once again this year, ESMO provided an opportunity to present research from the Medical Oncology group at the University of Verona and exchange findings and perspectives with the international oncology community.

Our poster presentations offered a platform to discuss our work, engage in scientific dialogue and identify directions for further research. Selected contributions included:

  • 4865P – Beyond class effect: A systematic review and meta-analysis of ADC-associated interstitial lung disease across 115 clinical trials and >17,000 patients
  • 2679P – Baseline and 3-month changes in lifestyle and QoL in advanced NSCLC patients eligible for immunotherapy
  • 4928eP – Understanding barriers to exercise promotion in patients with bone metastases: Results from a national survey of healthcare professionals

Through scientific sessions, discussions and shared experiences, we return to Verona with fresh perspectives and new research questions, reaffirming our commitment to integrating clinical care, research and education to improve patient outcomes.”

This also can be interesting:

What Changes in Lung Oncology After ESMO 2026? Survival Breakthroughs, ADC Competition, and a New Era of Precision Treatment

Marco Sposito: Bringing New Research Questions Back to Verona After ESMO 2026